miR-107 targets DKK1, while the expression of this Wnt/β-catenin signaling antagonist is negatively correlated with the levels of miR-107, LRP5, and β-catenin in osteosarcoma tissues. The gene discussed is DKK1; the disease is osteosarcoma.